CDC reports higher-than-normal flu cases, upticks in Southeast and South-Central U.S. … Long COVID found among 29% of survivors, women and severely ill most affected … Biden to sign order aiming to...
First human trial of Pfizer’s bivalent booster finds shot safe, effective
By
Alicia Lasek
Oct 14, 2022
New data from a trial in humans shows that the omicron-adapted COVID-19 booster made by Pfizer and BioNTech is safe and effective in older adults, according to the drugmakers.
Widespread use of statin-aspirin polypill would slash cardiovascular disease, experts contend
By
Alicia Lasek
Oct 14, 2022
The use of inexpensive combination pills could prevent cardiovascular disease on a wide scale, according to a commentary in The Lancet.
Clinical briefs for Friday, Oct. 14
By
Alicia Lasek
Oct 14, 2022
Black Medicare recipients far less likely to receive a surgical consultation: study … Ultra-low dose total body imaging could help docs better evaluate rheumatoid arthritis … Mediterranean diet has...
Polypharmacy rises before a dementia diagnosis: study
By
Alicia Lasek
Oct 13, 2022
Drug prescriptions increase in the 20 years before a patient’s dementia diagnosis, and prescribing patterns begin to hone in on particular medical conditions, a new study finds.
Common diabetes drug may serve as novel Afib treatment
By
Alicia Lasek
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.
Clinical briefs for Thursday, Oct. 13
By
Alicia Lasek
Oct 13, 2022
to lower mortality in ventilated COVID patients … MyndVR expands VR therapy for seniors with transatlantic partnership… FDA declines to approve Parkinson’s drug infusion pump
One quarter of clinicians say they want to switch careers, survey finds
By
Alicia Lasek
Oct 12, 2022
Some 25% of physicians, advanced practice providers and nurses surveyed said they are thinking about switching careers, and 33% want to leave their current employer.
Clinic reports no brain imaging abnormalities in patients given Aduhelm
By
Alicia Lasek
Oct 12, 2022
Brain scans showed no adverse side effects in patients treated with Aduhelm for Alzheimer’s disease, a neurology clinic study has found.
Clinical briefs for Wednesday, October 12
By
Alicia Lasek
Oct 12, 2022
Some providers dubious as return to pre-COVID “normal” gets official OK … University initiative aims to kickstart CNA interest, retention … Medicare enrollment at age 65 linked to improved healthcare...